| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
contributes to antibody suppression produced
by stress
1 Department of Kinesiology and Applied Physiology, 2 Department of Psychology, and 3 Center for Neuroscience, University of Colorado at Boulder, Boulder, Colorado 80309; and 4 Ethicon, Somerville, New Jersey 08876
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Acute stressor
exposure can facilitate innate immunity and suppress acquired
immunity. The present study further characterized the potentiating
effect of stress on innate immunity, interleukin-1
(IL-1), and
demonstrated that stress-induced potentiation of innate immunity may
contribute to the stress-induced suppression of acquired immunity. The
long-term effect of stress on IL-1 was measured by using an ex vivo
approach. Sprague-Dawley rats were challenged with lipopolysaccharide
(LPS) in vivo, and the IL-1 response was measured in vitro.
Splenocytes, mesenteric lymphocytes, and peritoneal cavity cells had a
dose- and time-dependent ex vivo IL-1 response to LPS. Rats that
were exposed to inescapable shock (IS, 100 1.6 mA, 5-s tail shocks,
60-s intertrial interval) and challenged with a submaximal dose
of LPS 4 days later had elevated IL-1 measured ex vivo. To test
whether the acute stress-induced elevation in IL-1 contributes to
the long-term suppression in acquired immunity, IL-1 receptors were
blocked for 24 h after stress. Serum anti-keyhole limpet
hemocyanin (KLH) immunoglobulin (Ig) was measured. In addition, the
acute elevation (2 h post-IS) of splenic IL-1 in the absence of
antigen was verified. Interleukin-1 receptor antagonist prevented
IS-induced suppression in anti-KLH Ig. These data support the
hypothesis that stress-induced increases in innate immunity (i.e.,
IL-1) may contribute to stress-induced suppression in acquired
immunity (i.e., anti-KLH Ig).
interleukin-1; interleukin-1 receptor antagonist; keyhole limpet
hemocyanin; lipopolysaccharide
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
ACUTE STRESSOR EXPOSURE MODULATES both innate and acquired immune function. It has been recently reported that stressor exposure can increase many measures of innate immunity. For example, the rate of benign (10, 17a) and infectious bacterial inflammation resolution (5), fever (17), macrophage/neutrophil nitric oxide (NO; Refs. 5, 8, 21), proinflammatory cytokines (29, 32, 37, 46, 50), acute-phase proteins (9, 18, 48), and complement activity (7, 17a) are all elevated after exposure to acute laboratory stressors. Exposure to acute stress can also suppress features of acquired immune function, for example, antigen-specific antibody (17, 20, 16, 25), T-cell proliferative (15, 19, 42), and cytotoxic T-lymphocyte (3) responses. Taken together, it is reasonable to suggest that exposure to acute stress can result in both, enhanced innate and suppressed acquired, immune function.
These seemingly opposing effects of stress on acquired and innate immunity may suggest that aspects of the facilitated innate immune responses are involved in the production of the inhibited acquired immune response. This direction of causation is suggested because the innate response typically lacks specificity and precedes the specific immune response in time. For example, exposure to 60 min of intermittent tail shock stress (IS) enhances nitric oxide (NO) production by macrophages for 2-4 days (21). NO is a key mediator of innate immune defense immunity (2, 13, 52) since it suppresses cellular proliferation of a broad class of pathogens. Thus stress-induced enhancement of NO production might well be adaptive. However, NO suppresses cellular proliferation nonspecifically, and so elevated NO at the time of antigen-specific lymphocyte proliferation could suppress that response and directly contribute to the stress-induced reduction in acquired immunity. Indeed, in vitro transfer of macrophages from a stressed rat into the lymphocyte culture from a nonstressed rat results in suppression of the T-cell proliferative response of the nonstressed rat (15). As expected from the present argument, the potentiated NO response also contributes to the positive consequences of the stress response. Our laboratory has recently reported that rats exposed to IS recover nearly 50% faster from Eschericia coli infection and that elevated NO at the inflammatory site contributes to this effect (5). Thus the combination of facilitated innate immunity and inhibited acquired immunity may result in a functional compensation, a possibility that has recently been suggested by Murray et al. (36).
The purpose of the present study was to further characterize the
long-term potentiating effect of stress on an additional measure of
innate immunity [interleukin-1 (IL-1)] and to determine whether
stress-induced potentiation of innate immunity is causally related to
stress-induced suppression of acquired immunity. To test this, we
explored whether 1) exposure to IS primes or potentiates the
IL-1 response to an important antigenic target on E. coli, lipopolysaccharide (LPS), 2) IS acutely increases
IL-1 in spleen and mesenteric lymph nodes, and 3)
IS-induced enhancement of IL-1 contributes to the suppression of
acquired immunity, specifically the antibody response against keyhole
limpet hemocyanin (anti-KLH Ig). We developed an ex vivo approach to
test whether stress produces a long-term potentiation of IL-1
production. Rats were challenged with LPS in vivo, but the IL-1
response was measured in vitro. This approach was necessary because
testing the hypothesis that stress-induced potentiation of IL-1
contributes to the stress-induced suppression in anti-KLH Ig requires
that the potentiated IL-1 response occur in immune tissues relevant
to the antibody response, such as the spleen. The early effect of
stress in the absence of LPS on tissue IL-1 concentrations in spleen
and mesenteric lymph nodes was also measured. The effect of IS on
circulating IL-1 has been previously reported (38). To
test whether acutely elevated IL-1 is necessary for long-term
stress-induced suppression of acquired immunity, IL-1 receptors were
blocked after stress, and serum anti-KLH Ig was measured.
| |
MATERIALS AND METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Subjects
Adult male Sprague-Dawley rats (4-10 per group; 300-350 g; Harlan Sprague Dawley, Indianapolis, IN) were individually housed in suspended metal wire cages (24.5 × 19 × 17.5 cm) with food and water available ad libitum. Colony conditions were maintained at 22°C on a 12:12-h light-dark cycle (lights on 0700-1900). Rats were given at least 2 wk to acclimate to the colony before experimental manipulation. Care and use of animals were in accordance with protocols approved by the University of Colorado Institutional Animal Care and Use Committee.LPS Administration
Time course study.
Before the impact of stress on IL-1 production could be tested, the
time course of ex vivo IL-1 production needed to be determined to
ensure an optimal response had been attained. Male Sprague-Dawley (4 mo) rats received intraperitoneal injections of either endotoxin- free
saline (Abbott Laboratories, North Chicago, IL) or LPS (400 µg/kg
E. coli endotoxin 0111:B4; lot number 86H18). Rats were
killed 1.5, 3, 5, or 24 h after injection. Data from the
saline-injected controls did not change across time, and so the data
for this group were pooled for the final analyses.
Dose-response study.
Before the impact of stress on IL-1 production could be tested, a
dose response of LPS was required to determine a dose that would result
in a suboptimal response. Animals (6 per group) received intraperitoneal injections of 0.5 ml of 20, 200, or 400 µg/kg of LPS
or endotoxin-free saline. Rats were killed 1.5 h after LPS challenge.
Stress LPS study. Four days after stress termination, animals were injected intraperitoneally with LPS or saline and killed 1.5 h later. The 4-day interval was chosen because previous work from our laboratory has found that NO potentiation is still present 4 days after IS in KLH immunized rats (21).
Stress Protocol
Animals (6 per group) either remained in their cages as controls or were placed in Plexiglas tubes (23.4 × 7.0 cm) and subjected to a tail-shock stress procedure. The stress procedure consisted of 100 5-s, 1.6-mA inescapable tail shocks (IS), with an average intertrial interval of 60 s and the entire procedure lasting 110 min. All stress procedures occurred between 0900 and 1100 h. After stress termination, rats were returned to their home cages.Splenic and Mesenteric Lymph Node IL-1 Concentrations 2 h
After Stress
concentrations in spleen and mesenteric lymph nodes was
measured in rats (6 per group) 2 h after exposure to IS, as
previously described. Rats were killed via decapitation. Spleen and
mesenteric lymph nodes were removed and flash frozen in liquid
nitrogen. Tissues were homogenized in homogenizing buffer (StressGen
Biotechnologies, and 1 protease inhibitor cocktail tablet, Boehringer
Mannheim, per 50 ml of extraction reagent). For each
~0.5-cm3 piece of tissue, 1 ml of homogenizing buffer was
used. Tissues were then dissociated with the use of sterile, modified,
glass tissue homogenizers. The extract was transferred to a
microcentrifuge tube and centrifuged at 21,000 g for 10 at
4°C. Supernatants were removed and stored at 
20°C until time of
assay. Presented IL-1 concentrations are corrected for total amount
of protein (Bradford).
KLH Administration
In experiments involving KLH antigen, rats received an intraperitoneal injection of 200 µg of soluble KLH (Calbiochem) in 0.5 ml of sterile endotoxin-free saline. Administration of KLH occurred immediately before IS or at an equivalent time for nonstressed control rats.Anti-KLH ELISA
Blood sampling. A blood sample for antibody assessment was quickly taken (within 2 min of touching cage) by gently wrapping the rat in a small towel and lightly restraining it using a Velcro strapping apparatus. A small nick was made in the exposed tail with a no. 15 scalpel, and a blood sample (300 µl) was quickly milked from the tail vein. This procedure was conducted at 0900 on days 5, 7, 10, and 14 post-KLH immunization. Anti-KLH IgM levels were measured in samples taken days 5, 7, 10, and 14. Anti-KLH IgG levels were measured only in samples taken on days 7, 10, and 14.
Anti-KLH IgM assessment. An ELISA was used for antibody assessment. Microtiter plates (96-well, Immulon-4, Dynex) were coated with 0.5 mg/ml dialyzed KLH for 3 days at 4°C. Plates were then washed and blocked with 5% bovine serum albumin (Sigma Chemical) overnight at 4°C. Serum samples were diluted (IgM 1:400, IgG 1:3,000) in phosphate- buffered saline (PBS) containing 0.05% Tween 20 (Sigma Chemical). A single serial dilution (1:2) of these concentrations was performed. These dilutions ensured that the sample concentration fell within the linear range of the plate reader. Microtiter plates were incubated for 3 h at 37°C and then washed with PBS-Tween 20. Secondary antibody, alkaline phosphatase-conjugated goat anti-rat IgM (1:5,500 dilution, Cappel) or alkaline phosphatase conjugated goat anti-rat IgG (1:2,000, Cappel) was added to each well for 60 min at 37°C. Plates were again washed three times before addition of p-nitrophenyl phosphate substrate (Sigma Chemical). Plates were incubated at room temperature in the dark until plate positive control wells registered an optical density of ~1.0 at 405 nm on a Dynatech plate reader. Results are presented as a percent change from nonstressed, drug- matched controls.
IL-1ra
Rats were injected subcutaneously with interleukin-1 receptor antagonist (IL-1ra; 100 mg · kg
1 · ml1 in
CSE buffer, Amgen) or CSE buffer (vehicle) every 4 h for
24 h after IS + KLH or no stress + KLH. This dosing
regimen of IL-1ra was chosen because we have previously reported it to
block stress-induced NO elevations measured 4 days after IS
termination (34).
Cell Culture Procedures
Animals were briefly anesthetized by exposure to ether and killed by cervical dislocation. Peritoneal cells were removed by lavage. Cold dissection medium (30.0 ml of Iscove's medium with 1% penicillin-streptomycin) was placed into the peritoneal cavity, the abdomen was briefly massaged, and the fluid was removed (20 ml). The medium was centrifuged, and the cells were resuspended to 2.0 × 106 cells/ml in culture medium (Iscove's medium containing 10% fetal bovine serum with 1% penicillin-streptomycin and 2 µM L-glutamine; all media reagents from GIBCO). Cells were counted using a Coulter particle counter. Mesenteric lymph node tissue and spleen were aseptically dissected and then placed in dissection medium over ice. Lymph nodes and spleens were dissociated using sterile, modified, glass tissue homogenizers. Lymph node and spleen cells were resuspended in culture medium at 10.0 × 106 cells/ml. One milliliter of each cell suspension was plated into a well of a 24-well flat-bottom culture plate (Falcon). Cells were cultured without additional stimulation at 37°C with 5% CO2. After 48 h, culture supernatant was collected and stored at20°C until time of assay.
Serum Collection
After ether anesthetization, but before cell or organ collection, blood was collected by cardiac puncture with a 23-gauge needle. Blood was allowed to clot for 30 min over ice before it was centrifuged. Serum was then collected and stored at20°C until assayed.
IL-1 Assessment
was measured from culture supernatants, tissue
supernatants, and serum with the use of a rat-specific ELISA kit (R&D Systems). Culture samples were assayed according to manufacturer's instructions. Tissue supernatants were assayed at optimal
concentrations (spleen, 1:40; lymph node, 1:10). Serum was assayed undiluted.
Statistical Analysis
A one-factor ANOVA was used to determine statistical differences for the LPS time course and dose-response study. Post hoc pairwise comparisons were performed using Fisher's least significant difference. For the study involving stress, a stress (home cage control vs. IS) by drug (saline vs. LPS) two-factor ANOVA was used. For the study involving IL-1ra and anti-KLH Ig, two-factor, repeated-measures ANOVAs were performed on the change from control anti-KLH Ig data. Statistical analyses were performed by using SuperAnova with a statistical difference accepted at
= 0.05.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Time Course of LPS Stimulation
As described above, animals received a high dose of LPS (400 µg/kg) and were killed either 1.5, 3, 5, or 24 h later. Splenocytes, mesenteric lymph node cells, and peritoneal cells were then placed in culture for 48 h with no additional stimulation. Figure 1 shows IL-1 measured in
supernatants from these cultures. A significant group difference was
detected [F(4,17) = 462.0, P < 0.01]. IL-1 production in splenocytes of rats
treated with LPS peaked after 1.5 h of stimulation and remained
significantly greater than vehicle control through the 5-h measurement
point (Fig. 1A, P < 0.01). A progressive
decrease in IL-1 production was measured at each time point and by
24 h of in vivo LPS stimulation IL-1 production returned to
control levels (P = 0.17).
|
Similar to splenocytes, mesenteric lymph node cells also exhibited
significant group differences [F(4,17) = 19.8, P < 0.01] in IL-1 production, with peak
levels also measured from cells with 1.5 h after in vivo LPS
stimulation (Fig. 1B). Post hoc tests confirmed that IL-1
levels were higher than saline control for the 1.5, 3, and 5 h
groups (P < 0.01) but returned to baseline after
24 h (P = 0.70). Likewise, a significant group
difference in IL-1 from LPS stimulated peritoneal cultures was
present [Fig. 1C, F(4,17) = 12.5, P < 0.01]. IL-1 production also peaked in cells stimulated for 1.5 h with LPS but approached control levels after 5 h (P = 0.07), and returned to vehicle
control levels at 24 h (P = 0.99).
Dose Response of LPS Stimulation
Results from the first study indicated that the peak IL-1
response measured in vitro occurred 1.5 h after in vivo LPS
stimulation. Therefore, this time was chosen to optimize dose-response
measures. IL-1 from cells taken from spleen, mesenteric lymph node,
and peritoneal lavage in response to various in vivo LPS doses is presented in Fig. 2,
A-C. Splenocyte production of IL-1
indicated a significant group effect
[F(3,20) = 97.8, P < 0.01]. All doses of LPS elevated IL-1 production over vehicle
control levels (P < 0.01). Additionally, animals given
the higher doses of LPS (200 or 400 µg/kg) produced significantly
more IL-1 than did animals given the 20 µg/kg dose
(P < 0.01). A significant group effect was also
detected for IL-1 production in cultured mesenteric lymphocytes
[Fig. 2B, F(3,20) = 7.14, P < 0.01]. Post hoc analyses confirmed that both the
200 and 400 µg/kg doses caused an elevation in IL-1 over vehicle
control (P < 0.01). The 20 µg/kg dose did not
significantly elevate IL-1 in lymph node cells (P = 0.38). Peritoneal cells stimulated in vivo with LPS for 1.5 h
produced a dose-dependent increase in IL-1 [Fig. 2C,
F(3,20) = 18.6, P < 0.01]. Similar to the spleen, all doses of LPS used significantly elevated IL-1 in peritoneal cells over vehicle control
(P < 0.05).
|
Stress and LPS Stimulation
To study the effects of tail shock stress on the response to LPS, a suboptimal dose of LPS was used to prevent a ceiling effect on IL-1 production. Therefore, the 20 µg/kg dose of LPS was chosen for this study. Additionally, prior work from our laboratory has shown
that the presence of antigen at the time of tail shock is necessary to
produce elevated NO responses 4 days after stressor termination (A. Moraska, unpublished results). The experimental design is depicted in
Fig. 3. Rats were injected, therefore,
with 200 µg ip of soluble KLH antigen immediately before tail shock. Four days after stressor termination, rats were injected with 20 µg/kg of LPS and killed 1.5 h later, and cells were removed and
cultured for an additional 48 h. IL-1 levels from splenocyte culture supernatants (Fig. 4A)
were increased by stress [F(1,20) = 4.92, P < 0.05] and LPS
[F(1,20) = 43.1, P < 0.01]. In addition, there was a significant stress × LPS
interaction [F(1,20) = 4.47, P < 0.05], indicating that stress potentiated the
effects of LPS. Mesenteric lymph node cultures (Fig. 4B)
showed a different pattern. There was a significant main effect for LPS
administration [F(1,20) = 6.28, P < 0.02], but no stress × LPS interaction
[F(1,20) = 1.26, P = 0.98]. The peritoneal cultures (Fig. 4C) yielded data similar to the mesenteric lymph nodes in that there was a main effect
of stress [F(1,20) = 26.0, P < 0.01] but no interaction [F(1,20) = 0.69, P = 0.42]. Interestingly, IL-1 concentrations in the supernatants from
cultured cells were not elevated by stress alone.
|
|
The pattern for the IL-1 response in the serum followed that for
splenocyte cultures (Fig. 5). LPS
significantly elevated serum IL-1
[F(1,18) = 20.0, P < 0.01] in both stress and nonstressed rats, but the elevation in
LPS-stimulated serum IL-1 was significantly greater in rats that
were stressed [F(1,18) = 4.23, P < 0.05].
|
Splenic and mesenteric lymph node IL-1 concentrations 2 h after
stress. Splenic [Fig. 6,
F(1,9) = 6.5, P < 0.05],
but not mesenteric lymph node [Fig. 6,
F(1,9) = 1.9, P = 0.2],
tissue concentration of IL-1 is elevated 2 h after IS
termination. The short-term increase occurred in the absence of LPS.
|
Stress and IL-1ra
Our laboratory has previously reported that exposure to IS reliably increases in circulating IL-1 at 0 h and 2 h, but
not 24 h, after IS termination (38). As shown in Fig.
6, IS also produces an increase in splenic IL-1 that is detectable
2 h after IS. To test the potential effect of this early
stress-induced increase in IL-1 on stress-induced suppression of
anti-KLH Ig, rats were injected with IL-1ra or vehicle every 4 h
for 24 h after IS or no stress. The experimental protocol is shown
in Fig. 7. Data are presented as a
percent change from not stressed, drug-matched control. IL-1ra reduced
the suppressive effect of IS on anti-KLH IgM (Fig.
8A) and anti-KLH IgG (Fig.
8B). A 2 (IL-1ra vs. vehicle) × 3 or 4 (days)
repeated-measure ANOVA revealed a trend for a reduction in the
stress-induced suppression of anti-KLH IgM
[F(3,60) = 2.5, P = 0.06] and reliable reduction in the suppression of anti-KLH IgG
[F(2,40) = 6.0, P < 0.01] across time.
|
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
LPS in vivo resulted in a large and sustained IL-1 response
that was detectable in vitro for at least 5 h after challenge. This response was dose dependent, with 20 µg/kg resulting in a submaximal response. The IL-1 response to in vivo LPS was produced by splenocytes, mesenteric lymphocytes, and peritoneal cavity cells.
However, only splenocytes had a potentiated IL-1 response to LPS
challenge given 4 days after IS termination.
It has been previously reported (28), that serum IL-1
responses to LPS challenge are also increased 4 days after IS. In these
studies, the long-lasting potentiated response only occurred if the LPS
challenge was given in vivo. If the cells were removed from the animal
after stress, and stimulated with LPS in vitro, no stress-induced
potentiation was found. In the present studies, an ex vivo approach was
used. This approach was advantageous because 1) the cells of
the immune system remained in the hormonal milieu when responding to
LPS and 2) the dissection of specific cell population
responses was possible. The present data suggest, therefore, that the
spleen may be an important source of the potentiated IL-1
concentration detected in the serum. This idea is further supported by
the fact that the concentration of IL-1 in the spleen is 10 times
that detected in the blood and could be primary source of the cytokine
detected in the serum.
Exposure to IS acutely (0-2 h) increases circulating IL-1
(37, 38), splenic IL-1 (Fig. 6) and NO production
(5, 21). Our laboratory has previously reported that
administration of IL-1ra after IS prevents the stress-induced
potentiation of NO 4 days after stressor exposure in KLH immunized rats
(34). Thus, in the present study, we tested whether IL-1ra
would also prevent stress-induced suppression of acquired immunity as
measured by serum anti-KLH Ig. The results were that administration of
IL-1ra did indeed reduce the immunosuppressive effect of IS on anti-KLH IgM and anti-KLH IgG. These data support the hypothesis that
stress-induced increases in innate immunity (i.e., IL-1) contribute
to stress-induced suppression in acquired immunity (i.e., anti-KLH Ig).
They also extend the previous observations of the effect of IS on
products released by cells of the innate immune system to also include IL-1.
Because the innate immune response is the arm of the immune response that is responsible for the "first line of defense" against infection, stress-induced priming of this response could be adaptive. That is, it is reasonable to suggest that an acutely stressed organism would be better able to mount a greater or faster response to antigenic challenge. It has been previously reported, for example, that exposure to acute stress potentiates responses of cells (neutrophils and macrophages) classically associated with innate immunity, and facilitates responses to antigens (E. coli and LPS) classically cleared by innate immune responses (5, 8, 10, 13, 14, 24, 33, 39, 41, 43-45, 49). The potentiating effect of acute stressor exposure (defined as a single exposure, <2 h in duration) on measures of innate immunity is pervasive in the literature. In fact, one is hard pressed to find exceptions to this rule. In the literature, if stress is reported to suppress measures of innate immunity, it commonly occurs after repeated stress sessions or a single stress session greater than 2 h in duration (30, 31, 53). Thus, if a stressor is chronic, the potentiating effect of stress on innate immunity can be lost.
Although the majority of the literature supports the suppressive effect of acute stress on acquired immunity, there are examples whereby acute stressor exposure potentiates measures of immunity involving T cells and nonbacterial antigen (11, 35). Interestingly, in these other studies, the antigenic challenge was administered to the skin or involved a relatively mild stressor. Perhaps, the potentiating effect of acute stress on acquired immunity occurred because the skin is often considered to be the most important tissue associated with innate immunity (27) or that moderate-intensity acute stressors tend to produce immunopotentiation. More work needs to be done before conclusions can be made.
The mechanism(s) responsible for the relatively long-lasting (up to 4 days after IS) potentiation of LPS-induced IL-1 production or NO are
not known. It seems unlikely that IS-induced changes in migration of
leukocytes could play a role in these effects since such changes are
quite short lived, usually disappearing within 24 h (17a,
19, 22). The data presented here suggest that IL-1 elevations
produced during and immediately after stress may play a role. IL-1
is known to stimulate NO release (12). Our laboratory has
previously reported (34) that IL-1ra administered every
4 h for 24 h after stress prevents the long-term (2-4
days after IS) increase in NO found in rats exposed to KLH + IS.
The potentiated NO response is likely to be involved in stress-induced suppression of anti-KLH T-cell proliferation, leading to suppression in
anti-KLH Ig (21, 15). The present study demonstrated that IL-1ra administered every 4 h for 24 h after stress prevents
anti-KLH Ig suppression, just as it prevents stress-induced enhancement of NO production. Thus IL-1 released during stress may be involved in priming subsequent antigen-stimulated IL-1 and NO responses. One
potential scenario is that exposure to IS increases circulating IL-1
(38) and splenic IL-1 (Fig. 6), leading to increased IL-1 receptor (IL-1r) expression on macrophages and neutrophils (4). Upregulation of IL-1r can persist for several
days, and so when the stressed organisms is exposed to antigen (LPS or
KLH), the cells of the innate immune system have an exaggerated IL-1 and NO response. In fact there is evidence that exposure to a single
session of restraint stress can increase IL-1r expression in the
pituitary (1, 26). The fact that both the IS-induced elevation in IL-1 and the potentiated LPS-stimulated NO response was
more robust in spleen compared with mesenteric lymph node lends support
to this idea.
There is also evidence supporting a role of stress-reactive hormones and peptides, such as substance P (51), catecholamines (47), and moderate levels of glucocorticoids (40), in potentiating neutrophil and macrophage function. The results of the present studies, however, do not address whether these hormones and peptides are involved in the mediation of IS-induced potentiation of innate immune function.
The finding that exposure to acute stress produced a long-lasting
potentiation in IL-1 responses to LPS, which may play an important
role in decreasing KLH-specific Ig, suggest that the immunological
response to acute stress is a "double-edged sword." Acute stressor
exposure, and in some circumstances chronic stress (36),
can increase features of the innate immune response, and this improved
innate response can be adaptive. If, however, the organism is
challenged with a pathogen or via a route that requires the
proliferation of T and B cells and the generation of an acquired immune
response, then the stress-induced enhancement of innate immunity could
be detrimental to host defense.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. Fleshner, Dept. of KAPH; Center for Neuroscience, Campus Box 354, Univ. of Colorado at Boulder, Boulder, CO 80309-0354 (E-mail: fleshner{at}colorado.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.01151.2001
Received 21 November 2001; accepted in final form 29 January 2002.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Ban, E,
Marquette C,
Sarrieau A,
Fitzpatrick F,
Fillion G,
Milon G,
Rostene W,
and
Haour F.
Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids.
Neuroendocrinology
58:
581-587,
1993[Web of Science][Medline].
2.
Bingisser, RM,
Tilbrook PA,
Holt PG,
and
Kees UR.
Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.
J Immunol
160:
5729-5734,
1998
3.
Bonneau, RH,
Brehm MA,
and
Kern AM.
The impact of psychological stress on the efficacy of anti-viral adoptive immunotherapy in an immunocompromised host.
J Neuroimmunol
78:
19-33,
1997[Web of Science][Medline].
4.
Bristulf, J,
and
Bartfai T.
Interleukin-1 and tumor necrosis factor- stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT-20 cells.
Neurosci Lett
187:
53-56,
1995[Web of Science][Medline].
5.
Campisi J, Leem TH, and Fleshner M. Acute stress decreases
inflammation at the site of infection: a role for nitric oxide.
Physiol Behav In press.
7.
Coe, CL,
Rosenberg LT,
and
Levine S.
Effect of maternal separation on the complement system and antibody responses in infant primates.
Int J Neurosci
40:
289-302,
1988[Web of Science][Medline].
8.
Coussons-Read, ME,
Maslonek KA,
Fecho K,
Perez L,
and
Lysle DT.
Evidence for the involvement of macrophage-derived nitric oxide in the modulation of immune status by a conditioned aversive stimulus.
J Neuroimmunol
50:
51-58,
1994[Web of Science][Medline].
9.
Deak, T,
Meriwether JL,
Fleshner M,
Spencer RL,
Abouhamze A,
Moldawer LL,
Grahn RE,
Watkins LR,
and
Maier SF.
Evidence that brief stress may induce the acute phase response in rats.
Am J Physiol Regulatory Integrative Comp Physiol
273:
R1998-R2004,
1997[Web of Science].
10.
Deak, T,
Nguyen KT,
Fleshner M,
Watkins LR,
and
Maier SF.
Acute stress may facilitate recovery from a subcutaneous bacterial challenge.
Neuroimmunomodulation
6:
344-354,
1999[Web of Science][Medline].
11.
Dhabar, FS.
Stress-induced enhancement of cell-mediated immunity.
Ann NY Acad Sci
840:
359-372,
1998[Web of Science][Medline].
12.
Fang, FC.
Perspectives series: host/pathogen interactions.
J Clin Invest
99:
2818-2825,
1997[Web of Science][Medline].
13.
Fecho, K,
Maslonek DA,
Coussons-Read ME,
Dykstra LA,
and
Lysle DT.
Macrophage-derived nitric oxide is involved in the depressed conconavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo.
J Immunol
152:
5845-5852,
1994[Abstract].
14.
Fielding, RA,
Manfredi TJ,
Ding W,
Fiatarone MA,
Evans WJ,
and
Cannon JG.
Acute phase response in exercise. III. Neutrophil and IL-1
accumulation in skeletal muscle.
Am J Physiol Regulatory Integrative Comp Physiol
265:
R166-R172,
1993
15.
Fleshner, M,
Bellgrau D,
Laudenslager ML,
Watkins LR,
and
Maier SF.
Stress-induced changes in the mixed lymphocyte reaction is dependent on macrophages but not on shifts in phenotypes.
J Neuroimmunol
56:
45-52,
1995[Web of Science][Medline].
16.
Fleshner, M,
Brennan FX,
Watkins LR,
and
Maier SF.
RU-486 blocks the suppressive effect of stress on the in vivo anti-KLH immunoglobulin response.
Am J Physiol Regulatory Integrative Comp Physiol
271:
R1344-R1352,
1996
17.
Fleshner, M,
Brohm M,
Watkins LR,
Laudenslager ML,
and
Maier SF.
Modulation of the in vivo antibody response by Benzodiazepine-inverse agonist (DMCM) given centrally or peripherally.
Physiol Behav
54:
1149-1154,
1993[Medline].
17a.
Fleshner, M,
Campisi J,
Deak T,
Greenwood BN,
Kintzel JA,
Leem TH,
Smith T,
and
Sorensen B.
Acute stressor exposure facilitates innate immunity more in physically active than sedentary rats.
Am J Physiol Regulatory Integrative Comp Physiol
282:
R1680-R1686,
2002
18.
Fleshner, M,
Deak T,
Spencer RL,
Laudenslager ML,
Watkins LR,
and
Maier SF.
A long term increase in basal levels of corticosterone and a decrease in corticosteroid-binding globulin after acute stressor exposure.
Endocrinology
136:
5336-5342,
1995[Abstract].
19.
Fleshner, M,
Hermann J,
Lockwood LL,
Watkins LR,
Laudenslager ML,
and
Maier SF.
Stressed rats fail to expand the CD45RC+CD4+ (Th1-like) T cell subset in response to KLH: possible involvement of IFN-.
Brain Behav Immun
9:
101-112,
1995[Web of Science][Medline].
20.
Fleshner, M,
Laudenslager ML,
Simons L,
and
Maier SF.
Reduced serum antibodies associated with social defeat in rats.
Physiol Behav
45:
1183-1187,
1989[Medline].
21.
Fleshner, M,
Nguyen KT,
Cotter CS,
Watkins LR,
and
Maier SF.
Acute stressor exposure both potentiates innate immunity and suppresses acquired immunity.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R870-R878,
1998
22.
Fleshner, M,
Watkins LR,
Bellgrau D,
Laudenslager ML,
and
Maier SF.
Specific changes in lymphocyte subpopulations: a potential mechanism for stress-induced immunosuppression.
J Neuroimmunol
41:
131-142,
1992[Web of Science][Medline].
24.
Gabriel, H,
Josef-Muler H,
Kettler K,
Brechtel L,
Urhausen A,
and
Kindermann W.
Increased phagocytic capacity of the blood, but decreased phagocytic activity per individual circulating neutrophil after an ultradistance run.
Eur J Appl Physiol
71:
281-284,
1995.
25.
Glaser, R,
Kiecolt-Glaser JK,
Bonneau RH,
Malarkey W,
Kennedy S,
and
Hughes J.
Stress-induced modulation of the immune response to recombinant hepatitis B vaccine.
Psychosom Med
54:
22-29,
1992
26.
Haour, F,
Marquette C,
Tsiang H,
Ban E,
Crumeyrolle-Arias M,
Rostene W,
and
Fillion G.
Interleukin-1 receptors in brain and pituitary. Characterization and modulation during infection and stress.
Ann NY Acad Sci
741:
324-337,
1994[Web of Science][Medline].
27.
Janeway, CA,
and
Travers P.
ImmunoBiology: The Immune System in Health and Disease. London: Current Biology/Garland, 1997.
28.
Johnson JD, O'Connor KA, Deak T, Stark M, Watkins LR, and Maier
SF. Prior stressor exposure sensitizes LPS-induced cytokine
production. Brain Behav Immun In press.
29.
Kimatura, H,
Konno A,
Morimatsu M,
Jung BD,
Kimura K,
and
Saito M.
Immobilization stress increases hepatic IL-6 expression in mice.
Biochem Biophys Res Commun
238:
707-711,
1997[Web of Science][Medline].
30.
Kizaki, T,
Oh-ishi S,
and
Ohno H.
Acute cold stress induces suppressor macrophages in mice.
J Appl Physiol
81:
393-399,
1996
31.
Kizaki, T,
Oh-ishi S,
Ookawara T,
Yamamoto M,
Izawa T,
and
Ohno H.
Glucocorticoid-mediated generation of suppressor macrophages with high density Fc RII during acute cold stress.
Endocrinology
137:
4260-4267,
1996[Abstract].
32.
LeMay, LG,
Vander AJ,
and
Kluger MJ.
The effects of psychological stress on plasma interleukin-6 in rats.
Physiol Behav
47:
335-342,
1990.
33.
Lysle, DT,
Fecho K,
Maslonek KA,
and
Dykstra LA.
Evidence for the involvement of macrophage-derived nitric oxide in the immunomodulatory effect of morphine and aversive Pavlovian conditioning.
Adv Exp Med Biol
373:
141-147,
1995[Medline].
34.
Maier, SF,
Fleshner M,
and
Watkins LR.
Neural, endocrine, and immune mechanisms of stress-induced immunomodulation.
In: New Frontiers in Stress Research: Modulation of Brain Function, edited by Levy A,
Grauer E,
Ben-Nathan D,
and de Kloet E. R.. Chur, Switzerland: Harwood Academic, 1998, p. 117-126.
35.
Moynihan, JA,
Karp JD,
Cohen N,
and
Cocke R.
Alterations in interleukin-4 and antibody production following pheromone exposure: role of glucocorticoids.
J Neuroimmunol
54:
51-58,
1994[Web of Science][Medline].
36.
Murray, SE,
Lallman HR,
Heard AD,
Rittenberg MB,
and
Stenzel-Poore MP.
A genetic model of stress displays decreased lymphocytes and impaired antibody responses without altered susceptibility to Streptococcus pneumoniae.
J Immunol
167:
691-698,
2001
37.
Nguyen, KT,
Deak T,
Owens SM,
Kohno T,
Fleshner M,
Watkins LR,
and
Maier SF.
Exposure to stress induces brain interleukin-1 protein in the rat.
J Neurosci
18:
2239-2246,
1998
38.
Nguyen, KT,
Deak T,
Will MJ,
Hansen MK,
Hunsaker BN,
Fleshner M,
Watkins LR,
and
Maier SF.
Time course and corticosterone sensitivity of the brain, pituitary, and serum interleukin-1 protein response to acute stress.
Brain Res
859:
193-201,
2000[Web of Science][Medline].
39.
Ortega, E,
Collazos ME,
Barriga C,
and
De La Fuente M.
Effect of physical activity stress on the phagocytic process of peritoneal macrophages from old guinea pigs.
Mech Ageing Dev
65:
157-165,
1992[Web of Science][Medline].
40.
Ortega, E,
Rodriguez MJ,
Barriga C,
and
Forner MA.
Corticosterone, prolactin and thyroid hormones as hormonal mediators of the stimulated phagocytic capacity of peritoneal macrophages after high-intensity exercise.
Int J Sports Med
17:
149-155,
1996[Web of Science][Medline].
41.
Peters-Futre, EM.
Vitamin C, neutrophil function, and upper respiratory tract infection risk in distance runners: the missing link.
Exerc Immunol Rev
3:
32-52,
1997[Web of Science][Medline].
42.
Plotnikoff, N,
Murgo A,
Faith R,
and
Wybran J.
Stress and Immunity. Boca Raton, FL: CRC, 1991.
43.
Smith, JA.
Moderate exercise triggers both priming and activation of neutrophil subpopulations.
Am J Physiol Regulatory Integrative Comp Physiol
270:
R838-R845,
1996
44.
Smith, JA,
McKenzie SJ,
Telford RD,
and
Weidemann MJ.
Why does moderate exercise enhance, but intense training depress, immunity?
Behav Immun
11:
155-168,
1992.
45.
Smith, JA,
and
Pyne DB.
Exercise, training, and neutrophil function.
Exerc Immunol Rev
3:
96-116,
1997[Web of Science][Medline].
46.
Takaki, A,
and
Huang QH.
Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines.
Neuroimmunomodulation
1:
335-342,
1994[Medline].
47.
Tsukahara, A,
Tada T,
Suzuki S,
Iiai T,
Moroda T,
Maruyama S,
Minagawa M,
Muksha N,
Shimizu T,
Hatakeyama K,
and
Abo T.
Adrenergic stimulation simultaneously induces the expansion of granulocytes and extrathymic T cells in mice.
Biomed Res (Tokyo)
18:
237-246,
1997.
48.
Van Gool, J,
van Vugt H,
Helle M,
and
Aarden LA.
The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat.
Clin Immunol Immunopathol
57:
200-210,
1990[Web of Science][Medline].
49.
Woods, JA,
Davis M,
Mayer EP,
Ghaffar A,
and
Pate R.
Exercise increases inflammatory macrophage antitumor cytotoxicity.
J Appl Physiol
75:
879-886,
1993
50.
Zhou, D,
Kusnecov AW,
Shurin MR,
DePaoli M,
and
Rabin BS.
Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis.
Endocrinology
133:
2523-2530,
1993
51.
Zhu, GF,
Chancellor-Freeland C,
Berman AS,
Kage R,
Leeman SE,
Beller DI,
and
Black PH.
Endogenous substance P mediates cold-water-stress-induced increase in interleukin-6 secretion from peritoneal macrophages.
Behav Neurosci
16:
3745-3752,
1996.
52.
Zidel, Z,
and
Masek K.
Erratic behavior of nitric oxide within the immune system: illustrative review of conflicting data and their immunopharmacological aspects.
Int J Immunopharmacol
20:
319-343,
1998[Web of Science][Medline].
53.
Zwilling, BS,
Brown D,
Christner R,
Faris M,
Hilburger M,
McPeek M,
Van Epps C,
and
Hartlaub BA.
Differential effect of restraint stress on MHC class II expression by murine peritoneal macrophages.
Brain Behav Immun
4:
330-338,
1990[Web of Science][Medline].
This article has been cited by other articles:
|
|
 |
|
  J. C. Pena-Philippides, S. Razani-Boroujerdi, S. P. Singh, R. J. Langley, N. C. Mishra, R. F. Henderson, and M. L. Sopori Long- and Short-Term Changes in the Neuroimmune-Endocrine Parameters following Inhalation Exposures of F344 Rats to Low-Dose Sarin Toxicol. Sci., May 1, 2007; 97(1): 181 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nickerson, G. F. Elphick, J. Campisi, B. N. Greenwood, and M. Fleshner Physical activity alters the brain Hsp72 and IL-1{beta} responses to peripheral E. coli challenge Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1665 - R1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fleshner and M. L. Laudenslager Psychoneuroimmunology: Then and Now Behav Cogn Neurosci Rev, June 1, 2004; 3(2): 114 - 130. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
